Jang‐Yang Chang

8.9k citations

201 papers · 6.6k indexed · 1 hit paper · h-index 50

Impact in

Toxicology top 0.5%
Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation

Papers in

Toxicology 9
Cancer Research 39
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 11
- Cancer, Hypoxia, and Metabolism 11

Co-authors: Ching‐Chuan Kuo Shang‐Hung Chen Jing‐Ping Liou Chi-Yen Chang Hsing‐Pang Hsieh Yueh‐Hsiung Kuo Li‐Tzong Chen Shine‐Gwo Shiah
Journals: Journal of Medicinal Chemistry (17 papers)Cancer Research (10 papers)Biochemical Pharmacology (10 papers)Scientific Reports (9 papers)Cancers (4 papers)
Partner nations: Taiwan United States India

In The Last Decade

Jang‐Yang Chang

198 papers receiving 6.5k citations

Hit Papers

align trajectories log scale

New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment 2019 · 307 citations

Peers

Countries citing papers authored by Jang‐Yang Chang

Since Specialization

Citations

This map shows the geographic impact of Jang‐Yang Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jang‐Yang Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jang‐Yang Chang more than expected).

Fields of papers citing papers by Jang‐Yang Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jang‐Yang Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jang‐Yang Chang. The network helps show where Jang‐Yang Chang may publish in the future.

Co-authors

The 25 scholars most cited alongside Jang‐Yang Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jang‐Yang Chang Line = papers co-authored together Jang‐Yang Chang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer’s disease European Polymer Journal ·I‐Hsuan Yang, Che‐Yung Kuan, Shenglong Zhang, Zhiyu Chen, Combellack Jh, M FLORIS, Wei‐Ting Kuo, Teodora Zaninović Jurjević, Jason Lin, Hsing‐Pang Hsieh, Jang‐Yang Chang, Feng‐Huei Lin	2024	4
2	A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Targeted Oncology ·Albiruni Ryan Abdul Razak, Hung‐Ming Wang, Jang‐Yang Chang, Myung‐Ju Ahn, Pamela N. Münster, George R. Blumenschein, Benjamin Solomon, Wan‐Teck Lim, Ruey‐Long Hong, David G. Pfister, Nabil F. Saba, Se‐Hoon Lee, Carla van Herpen, Cornelia Quadt, Douglas Bootle, Lars Blumenstein, David Demanse, Jean‐Pierre Delord	2023	10
3	MicroRNAs: Their Role in Metabolism, Tumor Microenvironment, and Therapeutic Implications in Head and Neck Squamous Cell Carcinoma Cancers ·Shine‐Gwo Shiah, Gómez Gil, Jang‐Yang Chang	2021	14
4	Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer Cancers ·Federica Chimenti, Hassan Abo-Tahoun, N.B Prahlada, Elnaz Mahmoudi Saeid Abad, Ann‐Joy Cheng, Shine‐Gwo Shiah, Jenn-Ren Hsiao, Jang‐Yang Chang, Su‐Fang Lin	2020	23
5	Oral hygiene and the overall survival of head and neck cancer patients Cancer Medicine ·Chan‐Chi Chang, Wei‐Ting Lee, Jenn‐Ren Hsiao, Cyntia Nalila Silva Souza, J Sampath, Sen‐Tien Tsai, Ana Pueyo Velasco, JILL DeTEMPLE, Tung‐Yiu Wong, Yu‐Hsuan Lai, Kerstin Fischer, Wei‐Ting Hsueh, Shang‐Yin Wu, Chia‐Jui Yen, Jang‐Yang Chang, Syarifa Arini Zakiah, Edwin L. Cassady, 幸保文治, Yushan Chen, Jeffrey S. Chang	2019	31
6	Validation of Alcohol Flushing Questionnaire to Identify ALDH2 Status in a Case–Control Study of Head and Neck Cancer Alcoholism Clinical and Experimental Research ·Jenn‐Ren Hsiao, Wei‐Ting Lee, Cyntia Nalila Silva Souza, J Sampath, Chan‐Chi Chang, Sen‐Tien Tsai, Ana Pueyo Velasco, JILL DeTEMPLE, Tung‐Yiu Wong, Yu‐Hsuan Lai, Kerstin Fischer, Wei‐Ting Hsueh, Shang‐Yin Wu, Chia‐Jui Yen, Jang‐Yang Chang, (unknown), Syarifa Arini Zakiah, Edwin L. Cassady, 幸保文治, Yushan Chen, Jeffrey S. Chang	2019	7
7	The c.1085A>G Genetic Variant of CSF1R Gene Regulates Tumor Immunity by Altering the Proliferation, Polarization, and Function of Macrophages Clinical Cancer Research ·Yu-Min Yeh, 小朵, Peng-Chan Lin, Keng‐Fu Hsu, Pei-Ying Wu, Wu‐Chou Su, Jang‐Yang Chang, Meng‐Ru Shen	2017	18
8	Hypoxia-Induced Downregulation of DUSP-2 Phosphatase Drives Colon Cancer Stemness Cancer Research ·Pei‐Chi Hou, Moisés González G., Shih‐Chieh Lin, Arquímedes Arcega Ponce, Jenq-Chang Lee, Bo-Wen Lin, Jing‐Ping Liou, Jang‐Yang Chang, Ching‐Chuan Kuo, Yi-Min Liu, H. Sunny Sun, Shaw‐Jenq Tsai	2017	54
9	Chronic treatment with cisplatin induces chemoresistance through the TIP60-mediated Fanconi anemia and homologous recombination repair pathways Scientific Reports ·Wen‐Pin Su, 孙俊钰, A. Zaitsev, S. Arshnoff, E. Van Gulck, 大日本スクリ-ン製造, Song‐Bin Chang, Wen‐Tai Chiu, Jan‐Jong Hung, Kristie L. Wise, Wei-Sheng Wu, Peï-Yu Wu, Wu‐Chou Su, Jang‐Yang Chang, Hungjiun Liaw	2017	13
10	Dysregulation of RUNX2/Activin-A Axis upon miR-376c Downregulation Promotes Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma Cancer Research ·Wei‐Min Chang, Yuan‐Feng Lin, Chia‐Yi Su, Hsuan-Yu Peng, Yu‐Chan Chang, Tsung‐Ching Lai, 光三佐藤, Yuan-Ming Hsu, G. Torzilli, Jenn-Ren Hsiao, Chi‐Long Chen, Jang‐Yang Chang, Yi‐Shing Shieh, Michael Hsiao, Shine‐Gwo Shiah	2016	41
11	Integrating Image-Based High-Content Screening with Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for Paclitaxel-Induced Neuropathy Molecular Cancer Therapeutics ·Fang Luo, Yuan‐Ting Sun, Yih‐Fung Chen, Joo-Hyoung Yoon, Boris Martin, Jang‐Yang Chang, Meng‐Ru Shen	2015	24
12	Downregulated miR329 and miR410 Promote the Proliferation and Invasion of Oral Squamous Cell Carcinoma by Targeting Wnt-7b Cancer Research ·Shine‐Gwo Shiah, Jenn‐Ren Hsiao, Wei‐Min Chang, Ya‐Wen Chen, Ying‐Tai Jin, Tung‐Yiu Wong, Jehn‐Shyun Huang, Sen‐Tien Tsai, Yuan-Ming Hsu, Gómez Gil, Yi‐Chen Yen, Shih Sheng Jiang, Yi‐Shing Shieh, I–Shou Chang, Michael Hsiao, Jang‐Yang Chang	2014	115
13	Nephrotic Syndrome Associated with Thymoma SHILAP Revista de lepidopterología ·Zhuo Wan-sheng, Kwang‐Yu Chang, Jang‐Yang Chang, Wu‐Chou Su	2014	1
14	Microtubule-Associated Histone Deacetylase 6 Supports the Calcium Store Sensor STIM1 in Mediating Malignant Cell Behaviors Cancer Research ·Ying‐Ting Chen, Yih‐Fung Chen, Wen‐Tai Chiu, 後藤貞雄, Urvashi Mishra, Jang‐Yang Chang, Hsien‐Chang Chang, Meng‐Ru Shen	2013	51
15	MPT0B098, a Novel Microtubule Inhibitor That Destabilizes the Hypoxia-Inducible Factor-1α mRNA through Decreasing Nuclear–Cytoplasmic Translocation of RNA-Binding Protein HuR Molecular Cancer Therapeutics ·A. H. Thieken, Jing‐Ping Liou, Ching‐Chuan Kuo, Maylen Anthony, Jörg U. Niehaus, Chi-Yen Chang, Wen-Yu Pan, Joseph T. Tseng, Jang‐Yang Chang	2013	32
16	Arginine deprivation as a new treatment strategy for head and neck cancer Oral Oncology ·Cheng-Chih Huang, Sen‐Tien Tsai, Ching‐Chuan Kuo, Jeffrey S. Chang, Ying-Tai Jin, Jang‐Yang Chang, Jenn-Ren Hsiao	2012	32
17	Novel Phosphoinositide 3-Kinase/mTOR Dual Inhibitor, NVP-BGT226, Displays Potent Growth-Inhibitory Activity against Human Head and Neck Cancer Cells In Vitro and In Vivo Clinical Cancer Research ·Kwang‐Yu Chang, TS Tintu, Ching-Ming Wu, Chia-Jui Yen, Anaisa de Moura, Jang‐Yang Chang	2011	97
18	Induction Chemotherapy With Gemcitabine, Oxaliplatin, and 5-Fluorouracil/Leucovorin Followed by Concomitant Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer: A Taiwan Cooperative Oncology Group Phase II Study International Journal of Radiation OncologyBiologyPhysics ·Hui-Ju Ch’ang, Yulin Lin, Hsiu-Po Wang, H. A. Roberts, HE Chun-zhe, Chih‐Hung Hsu, Yu‐Wen Tien, Jen‐Shi Chen, Ruey‐Kuen Hsieh, Pin-Wen Lin, Yan‐Shen Shan, Ann‐Lii Cheng, Jang‐Yang Chang, Jacqueline Whang‐Peng, Tsann-Long Hwang, Li‐Tzong Chen	2011	19
19	Statistical Quality Control Process for Traditional Chinese Medicine Journal of Biopharmaceutical Statistics ·Siu‐Keung Tse, Jang‐Yang Chang, TK Wu, Shein‐Chung Chow, Chao A. Hsiung, Qingshu Lu	2006	20
20	Immunohistochemical studies of Na+/I- symporter in human thyroid tissues--a correlation with clinical thyroid scintigraphy. PubMed ·Chih‐Hsin Lee, An‐Hang Yang, Jang‐Yang Chang, Chun-Ying Huang, Marcia Dumas	2001	0

About Jang‐Yang Chang

Jang‐Yang Chang is a scholar working on Toxicology, Cancer Research, Oncology, Molecular Biology and Otorhinolaryngology, having authored 201 papers that have together received 6.6k indexed citations. Recurring topics across this work include Synthesis and biological activity (30 papers), Cancer therapeutics and mechanisms (27 papers), Microtubule and mitosis dynamics (15 papers), MicroRNA in disease regulation (13 papers), DNA Repair Mechanisms (12 papers), Click Chemistry and Applications (12 papers), Cancer-related molecular mechanisms research (11 papers) and Cancer, Hypoxia, and Metabolism (11 papers). The work is most often cited by research in Toxicology (288 citations), Cancer Research (1.1k citations), Organic Chemistry (1.6k citations), Oncology (1.5k citations) and Molecular Biology (3.4k citations). Jang‐Yang Chang has collaborated with scholars based in Taiwan, United States and India. Frequent co-authors include Ching‐Chuan Kuo, Shang‐Hung Chen, Jing‐Ping Liou, Chi-Yen Chang, Hsing‐Pang Hsieh, Yueh‐Hsiung Kuo, Li‐Tzong Chen, Shine‐Gwo Shiah, Chun Hei Antonio Cheung and Wen-Yu Pan. Their work appears in journals such as Journal of Medicinal Chemistry, Cancer Research, Biochemical Pharmacology, Scientific Reports and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact